Partnerships
Collaborations
CromGenLab works with clinical groups at INCan, Mexican universities and research centers in Europe and the United States. It also works on the neurobiology of aging, axolotl regeneration and environmental pollution.
Other cancers we work on
Sarcomas
Radiomic markers of relapse in advanced synovial sarcoma.
Brain tumors
DAXX-ATRX and H3.3 regulation in gliomas and glioblastoma; germline variants in astrocytoma.
Ovarian cancer
Imaging-based predictive models of treatment resistance.
Epigenetic chromatin remodeling
Mexico
- Dra. Kioko Guzmán RamosUAM Lerma
- Dr. Ernesto Soto ReyesUAM Cuajimalpa
- Dra. Pamela Salcedo TelloSchool of Medicine, UNAM
- Dra. Clorinda AriasIIB, UNAM
- Dr. Luis A. HerreraINCan / UNAM
International
- Dr. Nicolás AlcarazUniversity of Copenhagen, Denmark
- Dr. Mehdi DamaghiStony Brook Cancer Center, USA
Molecular signatures in TGCT
Mexico
- Dra. Nora SobrevillaINCan, Oncology
- Dra. Talia Wegman OstroskyINCan
- Dr. Alejandro Mohar BetancourtINCan
- Dra. Alejandra CerveraINMEGEN
International
- Dr. Jan BaumbachUniversity of Hamburg, Germany
- Dr. Nicolás AlcarazUniversity of Copenhagen, Denmark
- Dr. Marius KlagesUniversity of Hamburg, Germany
- Dra. Julia Mendoza P.MD Anderson Cancer Center, USA
Funding
2018–2022FOSISS 2017 · Young Investigator
Molecular signatures predicting response to platinum-based chemotherapy in TGCT.
2023–2024FPIS Salud 2023
Epigenetic signatures associated with prediction of chemotherapy response in TGCT.
2024–2025Mexican Society of Oncology
Expression biomarkers associated with prediction of chemotherapy response in TGCT.